G. ÇETİN Et Al. , "Evaluation of clinical and laboratory findings with JAK2 V617F mutation as an independent variable in essential thrombocytosis," MOLECULAR BIOLOGY REPORTS , vol.41, no.10, pp.6737-6742, 2014
ÇETİN, G. Et Al. 2014. Evaluation of clinical and laboratory findings with JAK2 V617F mutation as an independent variable in essential thrombocytosis. MOLECULAR BIOLOGY REPORTS , vol.41, no.10 , 6737-6742.
ÇETİN, G., Ozkan, T., Turgut, S., Cikrikcioglu, M. A., Ar, M. C., Ayer, M., ... Unlu, A.(2014). Evaluation of clinical and laboratory findings with JAK2 V617F mutation as an independent variable in essential thrombocytosis. MOLECULAR BIOLOGY REPORTS , vol.41, no.10, 6737-6742.
ÇETİN, GÜVEN Et Al. "Evaluation of clinical and laboratory findings with JAK2 V617F mutation as an independent variable in essential thrombocytosis," MOLECULAR BIOLOGY REPORTS , vol.41, no.10, 6737-6742, 2014
ÇETİN, GÜVEN Et Al. "Evaluation of clinical and laboratory findings with JAK2 V617F mutation as an independent variable in essential thrombocytosis." MOLECULAR BIOLOGY REPORTS , vol.41, no.10, pp.6737-6742, 2014
ÇETİN, G. Et Al. (2014) . "Evaluation of clinical and laboratory findings with JAK2 V617F mutation as an independent variable in essential thrombocytosis." MOLECULAR BIOLOGY REPORTS , vol.41, no.10, pp.6737-6742.
@article{article, author={GÜVEN ÇETİN Et Al. }, title={Evaluation of clinical and laboratory findings with JAK2 V617F mutation as an independent variable in essential thrombocytosis}, journal={MOLECULAR BIOLOGY REPORTS}, year=2014, pages={6737-6742} }